305 related articles for article (PubMed ID: 12439603)
21. Immunotherapy for pancreatic cancer: current concepts.
Kaufman HL; Di Vito J; Hörig H
Hematol Oncol Clin North Am; 2002 Feb; 16(1):159-97, viii. PubMed ID: 12063825
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy of surgical malignancies.
Morse MA; Lyerly HK; Clay TM; Abdel-Wahab O; Chui SY; Garst J; Gollob J; Grossi PM; Kalady M; Mosca PJ; Onaitis M; Sampson JH; Seigler HF; Toloza EM; Tyler D; Vieweg J; Yang Y
Curr Probl Surg; 2004 Jan; 41(1):15-132. PubMed ID: 14749625
[No Abstract] [Full Text] [Related]
23. Immunotherapy of human tumors.
Sinkovics JG
Pathobiol Annu; 1978; 8():241-84. PubMed ID: 364375
[No Abstract] [Full Text] [Related]
24. Common cancers--immunotherapy and multidisciplinary therapy: Parts III and IV.
Quan WD; Palackdharry CS
Dis Mon; 1997 Nov; 43(11):745-808. PubMed ID: 9400420
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapy for treating metastatic colorectal cancer.
Boghossian S; Robinson S; Von Delwig A; Manas D; White S
Surg Oncol; 2012 Jun; 21(2):67-77. PubMed ID: 21292476
[TBL] [Abstract][Full Text] [Related]
26. [The role of immunotherapy in the treatment of cancer].
Tubiana M
Bull Acad Natl Med; 1992 Jun; 176(6):859-65; discussion 865-6. PubMed ID: 1464031
[TBL] [Abstract][Full Text] [Related]
27. Active specific immunotherapy of human solid tumors.
Rosato FE; Miller E; Rosato EF
Va Med; 1978 Mar; 105(3):221-3. PubMed ID: 636545
[TBL] [Abstract][Full Text] [Related]
28. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
Moschella F; Proietti E; Capone I; Belardelli F
Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
[TBL] [Abstract][Full Text] [Related]
29. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
Zöller M; Matzku S
Arch Immunol Ther Exp (Warsz); 2002; 50(3):197-224. PubMed ID: 12098935
[TBL] [Abstract][Full Text] [Related]
30. [Immunotherapy: Activation of a system not a pathway].
Bernichon E; Rancoule C; Vallard A; Langrand-Escure J; Mery B; Guy JB; Magné N
Bull Cancer; 2017 May; 104(5):462-475. PubMed ID: 28477871
[TBL] [Abstract][Full Text] [Related]
31. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
[TBL] [Abstract][Full Text] [Related]
32. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
[TBL] [Abstract][Full Text] [Related]
33. [The surgeon and the immunotherapy of cancer].
Mathé G
J Chir (Paris); 1975 Sep; 110(3):241-8. PubMed ID: 1219038
[TBL] [Abstract][Full Text] [Related]
34. [Immediate tasks and the potentials of conducting immunotherapy of malignant neoplasms].
Gorodilova VV
Vopr Onkol; 1979; 25(3):37-43. PubMed ID: 373240
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cell vaccination of patients with metastatic colorectal cancer.
Burgdorf SK
Dan Med Bull; 2010 Sep; 57(9):B4171. PubMed ID: 20816019
[TBL] [Abstract][Full Text] [Related]
36. [Immunotherapy of human cancers. "Leukemia, hematosarcomas and solid tumors].
Mathé G
Nouv Presse Med; 1975 May; 4(18):1333,1335-6. PubMed ID: 1098014
[No Abstract] [Full Text] [Related]
37. Therapeutic vaccines for cancer: an overview of clinical trials.
Melero I; Gaudernack G; Gerritsen W; Huber C; Parmiani G; Scholl S; Thatcher N; Wagstaff J; Zielinski C; Faulkner I; Mellstedt H
Nat Rev Clin Oncol; 2014 Sep; 11(9):509-24. PubMed ID: 25001465
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy for metastatic colorectal cancer: present status and new options.
Ellebaek E; Andersen MH; Svane IM; Straten PT
Scand J Gastroenterol; 2012 Mar; 47(3):315-24. PubMed ID: 22214467
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy for melanoma.
Komenaka I; Hoerig H; Kaufman HL
Clin Dermatol; 2004; 22(3):251-65. PubMed ID: 15262312
[TBL] [Abstract][Full Text] [Related]
40. Novel approaches to the immunotherapy of B-cell malignancies: An update.
Brentjens RJ
Curr Hematol Malig Rep; 2006 Dec; 1(4):258-63. PubMed ID: 20425321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
